Sebastian Irmer

Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06/99 and 07/03 trials

Thorsten Raff, Nicola Gökbuget, Silke Lüschen et al. · Blood · 2006 · 238 citations · Full text

Medicine, Molecular Medicine, Oncology +15

Immunochemotherapy with Rituximab Improves Molecular CR Rate and Outcome In CD20+ B-Lineage Standard and High Risk Patients; Results of 263 CD20+ Patients Studied Prospectively In GMALL Study 07/2003

Dieter Hoelzer, Andreas Huettmann, Felix Kaul et al. · Blood · 2010 · 83 citations

Life Sciences, Immunology, Oncology +12

High Survival Rate in Adult Burkitt’s Lymphoma/Leukemia and Diffuse Large B-Cell Lymphoma with Mediastinal Involvement.

Dieter Hoelzer, Wolfgang Hiddemann, Anita Baumann et al. · Blood · 2007 · 37 citations

Medicine, Hematology, Oncology +11